Botulinum toxin for spasticity and athetosis in children with cerebral palsy

Archives of Physical Medicine and Rehabilitation

Volumn 77, Issue 5, 1996, Pages 508-511

  Gooch, Judith L ^a   Sandell, Timothy V ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CLORAZEPATE; DANTROLENE;

ADOLESCENT; ARTICLE; ATHETOSIS; CASE REPORT; CEREBRAL PALSY; CHILD; CHILDHOOD DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MUSCLE TONE; NEUROLOGIC DISEASE; SPASTICITY; TREATMENT OUTCOME;

EID: 0029996515     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(96)90042-8     Document Type: Article

References (13)

1. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-94.
2. Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology. Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Neurology 1990;40:1332-6.
3. Das TK, Park DM. Botulinum toxin in treating spasticity. Br J Clin Pharmacol 1989;43:401-3.
4. Snow BJ, Tsui JK, Bhatt MH. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28:512-5.
5. Koman CA, Modney JF, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993;13:489-95.
6. Cony IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double blind trial [abstract]. Dev Med Child Neurol 1994;Suppl 70:11.
7. Chutorian AM, Root L. Management of spasticity in children with botulinum-A toxin. Int Pediatrics 1994;9:35-43.
8. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-96.
9. Sutherland DH, Kaufman KR, Wyatt MP, Mubarak SJ. Effects of botulinum toxin on gait of patients with cerebral palsy: preliminary results [abstract]. Dev Med Child Neurol 1994;Suppl 70:11.
10. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disordered motor control. Chicago: Yearbook Medical, 1980:485-94.
11. O'Brien C. Management of spasticity associated with stroke. In: O'Brien C, Yablons S, editors. Management of spasticity with botulinum toxin. Littleton (CO): Postgraduate Institute for Medicine, 1995:7-10.
12. Yablon S. Management of spasticity associated with traumatic brain injury. In: O'Brien C, Yablon S, editors. Management of spasticity with botulinum toxin. Littleton (CO): Postgraduate Institute for Medicine, 1995:11-5.
13. Siatkowski RM, Tyutyunikov A, Biglan AW, Scalise D, Genovese C, Raikow R, et al. Serum antibody production to botulinum A toxin. Ophthalmology 1993;100:1861-6.